News | May 07, 2012

India's Bhubaneswar Borooah Cancer Institute Acquires New Linac

May 7, 2012 — Prime Minister of India Manmohan Singh honored the Bhubaneswar Borooah Cancer Institute (BBCI) by presiding over the inauguration of its Elekta Synergy linear accelerator on April 20 in Guwahati in the Indian state of Assam. The Synergy system joins BCCI's first Elekta treatment system, which was installed in 2000. Established in 1973, the BBCI is among the leading cancer institutes of east India and was recognized as a Regional Cancer Centre in 1980.

"It was very gratifying to have an influential public figure such as Dr. Singh recognize the importance of increasing access to medical technology in India — which will hopefully influence the decision-making process at other regional hospitals that are seeking to invest in linear accelerators," said Brendhan Vahey, managing director, Elekta India.

Elekta and other healthcare providers have partnered with medical centers and clinics across India to address a serious shortage of radiation therapy equipment. India's population of 1.21 billion significantly dwarfs the number of radiotherapy systems available to its residents, Vahey adds.

"To match a developed nation's ratio of inhabitants to linear accelerators alone, India would need about 10 times as many treatment systems," he said. "Fortunately, the Indian radiation therapy market is growing at an unprecedented rate — over 15 percent per year — almost double its current GDP growth."

BBCI's new Synergy system is fully equipped with the most advanced radiation therapy techniques in use today, including intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

In Assam, head-and-neck cancer and tobacco-related cancers (mainly lung cancer) comprise 15-20 percent of total cancers. Among males, the top three cancer incidences are oral cavity, larynx and lung cancer, while in women, cervical and breast cancers are the most common. In metro areas, prostate and breast cancer incidences are rising. At any given time in India, there are about three million individuals who have cancer, with approximately 960,000 new cases identified per year. A national task force estimates that two-thirds of those diagnosed with cancer will need radiation therapy.

"We will continue to see a tremendous need for cancer care in India for many years to come," Vahey said. "As a leading supplier of comprehensive solutions for cancer management in India, it is Elekta's responsibility to work closely with healthcare professionals to make these advanced solutions available to the public."

For more information: www.elekta.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation